1607 Capital Partners’s BlackRock Health Sciences Term Trust BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.16M Sell
428,486
-13,727
-3% -$222K 0.65% 40
2026
Q2
$6.79M Sell
442,213
-72,260
-14% -$1.04M 0.59% 46
2026
Q1
$7.39M Buy
+514,473
New +$7.64M 0.53% 46
2025
Q2
– Sell
-759,827
Closed -$11.3M – 121
2025
Q1
$11.3M Sell
759,827
-42,852
-5% -$671K 0.91% 33
2024
Q4
$11.6M Sell
802,679
-235,179
-23% -$3.64M 0.93% 35
2024
Q3
$16.4M Sell
1,037,858
-140,642
-12% -$2.22M 1.5% 15
2024
Q2
$18.1M Sell
1,178,500
-164,265
-12% -$2.49M 1.62% 15
2024
Q1
$22M Sell
1,342,765
-215,566
-14% -$3.4M 1.79% 9
2023
Q4
$22.8M Sell
1,558,331
-15,450
-1% -$216K 1.6% 13
2023
Q3
$22.7M Sell
1,573,781
-8,300
-0.5% -$129K 1.7% 12
2023
Q2
$26M Buy
1,582,081
+9,855
+0.6% +$161K 1.86% 11
2023
Q1
$26.3M Buy
1,572,226
+56,861
+4% +$916K 1.85% 11
2022
Q4
$23.4M Buy
1,515,365
+479,689
+46% +$7.43M 1.61% 17
2022
Q3
$15.5M Buy
1,035,676
+199,594
+24% +$3.3M 1.2% 26
2022
Q2
$13.7M Buy
836,082
+478,058
+134% +$8.2M 0.94% 31
2022
Q1
$7.18M Buy
358,024
+120,947
+51% +$2.51M 0.42% 57
2021
Q4
$6.01M Buy
237,077
+13,410
+6% +$346K 0.32% 59
2021
Q3
$6.04M Sell
223,667
-113,866
-34% -$3.26M 0.3% 58
2021
Q2
$9.8M Sell
337,533
-86,392
-20% -$2.39M 0.47% 51
2021
Q1
$11.1M Buy
+423,925
New +$12M 0.54% 50

Other funds holding BMEZ

1607 Capital Partners's BMEZ Position: Q3 2026 in Review

1607 Capital Partners reduced its BlackRock Health Sciences Term Trust (BMEZ) stake by 3.1% in Q3 2026, selling an estimated $222K and leaving 428,486 shares worth $7.16M. The position accounts for 0.65% of the portfolio, ranked #40.

1607 Capital Partners first reported a position in BMEZ in Q1 2021 and has held it in 20 quarters since. The position peaked at $26.3M in Q1 2023. 89 funds tracked by Wall St. Rank hold BMEZ as of Q3 2026.

  • 1607 Capital Partners held 428,486 shares of BlackRock Health Sciences Term Trust worth $7.16M as of Q3 2026.
  • 1607 Capital Partners sold 13,727 BlackRock Health Sciences Term Trust shares in Q3 2026, an estimated $222K.
  • BlackRock Health Sciences Term Trust made up 0.65% of 1607 Capital Partners's portfolio in Q3 2026, its #40 holding.
  • 1607 Capital Partners first reported a position in BlackRock Health Sciences Term Trust in Q1 2021 and has held it in 20 quarters since.
  • 1607 Capital Partners's BlackRock Health Sciences Term Trust position peaked at $26.3M in Q1 2023.
  • 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Term Trust as of Q3 2026.

Based on 1607 Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.